Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases
- 161 Downloads
Insulin-like growth factor-1 receptor (IGF1R) plays a key role in cell growth and transformation. It is overexpressed in several solid tumors. This study evaluates IGF1R immunoexpression in penile squamous cell carcinoma (SCC). Four tissue microarrays were built from formalin-fixed, paraffin-embedded blocks of 112 penile SCC from Paraguay. Membranous IGF1R expression was evaluated by immunohistochemistry using two different approaches. An H-score was calculated in each spot (stain intensity by extent), and a median score per tumor was obtained. The second approach consisted of a score similar to the scoring system that was used for evaluating HER2 immunoexpression. For each case, the highest category obtained at any spot was used for statistical analyses. IGF1R expression was compared by histologic subtype, grade, and human papillomavirus (HPV) status. Median H-score was 22.5. The distribution of IGF1R expression by HER2 approach was as follows: 0 in 33.0% cases, 1+ in 46.4%, 2+ in 14.3%, and 3+ in 6.2%. IGF1R H-scores were associated with basaloid and warty/basaloid subtypes (p = 0.0026) and higher grade (p = 0.00052). Although weaker when using the HER2 approach, the association of IGF1R expression with subtype (p = 0.015) and grade (p = 0.015) remained significant. Furthermore, there was an association between IGF1R expression by HER2 approach and HPV status (p = 0.012). IGF1R was expressed in about two thirds of penile SCC cases, showing a strong positive association with histologic grade, subtype, and HPV status. Considering that grade is a predictor of outcome IGF1R expression may have prognostic relevance and could point to a potential role for IGF1R inhibitors in treating penile SCC.
KeywordsIGF1R Penile carcinoma Squamous cell carcinoma
We acknowledge the outstanding work of Helen Fedor and Marcella Southerland, from the TMA Lab Core at the Johns Hopkins University, in building the TMAs for the study.
Compliance with ethical standards
This study was partially supported by the Johns Hopkins Medicine—Patana Fund for Research. Dr. Alcides Chaux was partially supported by an award granted by the National Council of Science and Technology (CONACYT) dependent of the Presidency of the Republic of Paraguay, as an Active Researcher of Level 2 of the National Incentive Program for Researchers (PRONII).
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Cubilla AL, Amin MB, Ayala A et al (2016) Tumours of the penis. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC, Lyon, p 259–285Google Scholar
- 3.Ball MW, Bezerra SM, Chaux A, Faraj SF, Gonzalez-Roibon N, Munari E, Sharma R, Bivalacqua TJ, Netto GJ, Burnett AL (2016) Overexpression of insulin-like growth factor-1 receptor is associated with penile cancer progression. Urology 92:51–56. doi: 10.1016/j.urology.2016.02.006 CrossRefPubMedGoogle Scholar
- 6.Chaux A, Munari E, Cubilla AL, Hicks J, Lecksell K, Burnett AL, Netto GJ (2014) Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Histopathology 64:863–871. doi: 10.1111/his.12338 CrossRefPubMedGoogle Scholar
- 7.Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, Burnett AL, Netto GJ (2013a) The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol 44:2690–2695. doi: 10.1016/j.humpath.2013.07.012 CrossRefPubMedGoogle Scholar
- 8.Chaux A, Netto GJ, Rodriguez I, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Bosch FX, Sanjose S, Munoz N, Hildesheim A, Cubilla AL (2013b) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31:861–867. doi: 10.1007/s00345-011-0802-0 CrossRefPubMedGoogle Scholar
- 9.Chaux A, Torres J, Pfannl R, Barreto J, Rodriguez I, Velazquez EF, Cubilla AL (2009) Histologic grade in penile squamous cell carcinoma visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of a Gleason-like system with nodal metastasis. Am J Surg Pathol 33:1042–1048CrossRefPubMedGoogle Scholar
- 10.Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Velazquez EF, Lezcano C, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Munoz N, Quint W, de Sanjose S, Bosch FX (2010) The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol 34:104–114CrossRefPubMedGoogle Scholar
- 11.Dale OT, Aleksic T, Shah KA, Han C, Mehanna H, Rapozo DCM, Sheard JDH, Goodyear P, Upile NS, Robinson M, Jones TM, Winter S, Macaulay VM (2015) IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer. Carcinogenesis 36:648–655. doi: 10.1093/carcin/bgv053 CrossRefPubMedGoogle Scholar
- 13.Ferrandiz-Pulido C, Masferrer E, Toll A, Hernandez-Losa J, Mojal S, Pujol RM, Cajal SRY, de Torres I, Garcia-Patos V (2013) mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior. J Urol 190:2288–2295. doi: 10.1016/j.juro.2013.06.015 CrossRefPubMedGoogle Scholar
- 14.Gonzalez-Roibon N, Kim JJ, Faraj SF, Chaux A, Bezerra SM, Munari E, Ellis C, Sharma R, Keizman D, Bivalacqua TJ, Schoenberg M, Eisenberger M, Carducci M, Netto GJ (2014) Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy. Urology 83:1444.e1441–1444.e1446. doi: 10.1016/j.urology.2014.01.028 CrossRefGoogle Scholar
- 17.Kakies C, Lopez-Beltran A, Comperat E, Erbersdobler A, Grobholz R, Hakenberg OW, Hartmann A, Horn LC, Höhn AK, Köllermann J, Kristiansen G, Montironi R, Scarpelli M, Protzel C (2014) Reproducibility of histopathologic tumor grading in penile cancer—results of a European project. Virchows Arch 464:453–461. doi: 10.1007/s00428-014-1548-z CrossRefPubMedGoogle Scholar
- 19.Kuklinski A, Kamocki Z, Koda M, Piotrowski Z, Sulkowski S, Lesniewicz R, Pawlak K, Mysliwiec P, Kedra B (2011) IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: initial report. Oncol Lett 2:1155–1159. doi: 10.3892/ol.2011.396 PubMedPubMedCentralGoogle Scholar
- 21.Matsumoto F, Fujimaki M, Ohba S, Kojima M, Yokoyama J, Ikeda K (2015) Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer head and neck-journal for the sciences and specialties of the. Head Neck 37:977–981. doi: 10.1002/hed.23702 CrossRefPubMedGoogle Scholar
- 23.Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WGV, Pirog EC (2001) Detection and typing of human papillomavirus DNA in penile carcinoma—evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159:1211–1218. doi: 10.1016/s0002-9440(10)62506-0 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, Lu YJ, Watkin N, Corbishley C, Lam W, Berney DM (2011) Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. Plos One 6. doi: 10.1371/journal.pone.0017517
- 27.Team RC (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
- 29.Verhoeven RHA, Janssen-Heijnen MLG, Saum KU, Zanetti R, Caldarella A, Holleczek B, Brewster DH, Hakulinen T, Horenblas S, Brenner H, Gondos A, Grp ESW (2013) Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 49:1414–1421. doi: 10.1016/j.ejca.2012.10.029 CrossRefPubMedGoogle Scholar